17h
AZoLifeSciences on MSNNew CRISPR Tool Reveals Key Lymphoma GenesThis study presents an optimized CRISPR-Cas12a system for large-scale genetic screening, revealing critical genes involved in lymphoma development and therapy.
Beans are a key food at the dietary level, boasting high nutritional value and constituting the most directly consumed legume ...
EST Cathie Wood’s ARK Investment buys 187K shares of Crispr Therapeutics (CRSP) todayMaximize Your Portfolio with Data Driven ...
At the Third International Summit on Human Genome Editing, held in March 2023 at the Francis Crick Institute in London, ...
2d
AZoLifeSciences on MSNCRISPR-Engineered Fat Cells Show Promise in Preclinical Cancer ModelsCancer is rarely discussed alongside liposuction or plastic surgery. However, a groundbreaking approach to cancer treatment ...
The field of plant biotechnology is undergoing a profound transformation. The rise of generative artificial intelligence (AI) ...
Akribion Therapeutics emerges from stealth with €8 million in seed funding to develop a novel cancer RNA-guided approach ...
Precision medicine is revolutionizing healthcare, and these genomic stocks are leading the way. Therefore, as this sector ...
By creating gene editors not found in nature, or optimizing existing editors, AI can improve the accuracy, effectiveness, and accessibility of gene editing.
Encasing CRISPR tools in oil droplets offers a fast-track approach to conducting extensive genetic screens in animals.
Vertex Pharmaceuticals (VRTX) stock has performed strongly since the turn of the year, gaining 14.6% and vastly outperforming the healthcare ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results